Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non–small-cell lung cancer

This publication has 22 references indexed in Scilit:

• The current state of paclitaxel and radiation in the combined-modality therapy of non-small cell lung cancer
  Seminars in Oncology, 2001
• Optimizing chemoradiation therapy approaches to unresectable stage III non–small cell lung cancer
  Current Opinion in Oncology, 2001
• Sequential vs. concurrent chemotherapy and radiation therapy for inoperable non-small cell lung cancer (NSCLC): Analysis of failures in a phase III study (RTOG 9410)
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Recursive partitioning analysis of 1999 radiation therapy oncology group (RTOG) patients with locally-advanced non–small-cell lung cancer (LA-NSCLC): Identification of five groups with different survival
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Innovative Treatment Strategies in Locally Advanced and/or Unresectable Non-Small Cell Lung Cancer
  Cancer Control, 2000
• Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 1999
• Cancer statistics, 1999
  CA: A Cancer Journal for Clinicians, 1999
• Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial
  JNCI Journal of the National Cancer Institute, 1996
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
  BMJ, 1995
• Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma
  Lung Cancer, 1994